MAP2K7 and cancer: As well, assessed the role of targeted bee venom-CSNPs on EGFR-mediated tyrosine kinase cascades; MEK/ERK, and p38-MAPK to support the rationale for applying natural compounds-based nanomaterials in clinical trials for cancer therapy.